D.-H. Yoon et al. / Tetrahedron Letters 51 (2010) 2181–2183
2183
Acknowledgments
RNH2
re
H
H
Y
X
N
H
H
This work was supported by the HUFS Grant (2010) and Korea
Science and Engineering Foundation (R01-2007-000-20037-0 for
H.-J.H and KRF-2008-C00481 and NRF-2009-0081956 for W.K.L.).
X
N
CO2Me
Ph
Y
si
N
(b)
(a)
RNH2
(C)
Me
Supplementary data
Figure 2. (a), (b) Front and side views of the aziridine with two substituents X and
Y at N1 and C2. (c) View of methyl cis-3-[{(10R)-phenylethylaziridin}-(2R)-yl]-
acrylate (1) and the possible approaching faces of the amine nucleophile in the
transition state model.
Supplementary data (experimental procedures and character-
ization data for all new compounds) associated with this article
Me
Me
References and notes
BocHN
Me
NH2
ii
HN
Ph
i
Ph
N
CO2Me
1. For reviews on the chemistry of 1,2-diamines, see: (a) Kotti, S. R. S. S.;
Timmons, C.; Li, G. Chem. Biol. Drug Design. 2006, 67, 101; (b) Fache, F.; Schulz,
E.; Tommasino, M. L.; Lemaire, M. Chem. Rev. 2000, 100, 2159; (c) Lucet, D.; Le
Gall, T.; Mioskowski, C. Angew. Chem., Int. Ed. 1998, 37, 2580.
2. (a) Hoang, C. T.; Alezra, V.; Guillot, R.; Kouklovsky, C. Org. Lett. 2007, 9, 2521;
(b) Lehmann, T.; Michel, D.; Glänzel, M.; Waibel, R.; Gmeiner, P. Heterocycles
1999, 51, 1389.
Me
CO2H
NHBoc
O
N
H
H
3Ac
8
7
Scheme 2. Reagents and conditions: (i) (1) H2 (1 atm), Pd(OH)2, rt. 4 h, (2) (Boc)2O,
MeOH, rt, two steps 89%. (ii) LiOH, EtOH/H2O = 5:1 (v/v) 50 °C, 8 h, rt, ion-exchange
column, 82%.
3. Jones, D. M.; Sueiras-Diaz, J.; Szelke, M.; Leckie, B. J.; Beattie, S. R.; Morton, J.;
Neidle, S.; Kuroda, R. J. Pept. Res. 1997, 50, 109.
4. (a) Skropeta, D. Nat. Prod. Rep. 2008, 25, 1131; (b) Hoang, C. T.; Nguyen, V. H.;
Alezra, V.; Kouklovsky, C. J. Org. Chem. 2008, 73, 1162; (c) Bewley, C. A.; Debitus,
C.; Faulkner, D. J. J. Am. Chem. Soc. 1994, 116, 7631.
5. Iwanami, S.; Takashima, M.; Hirata, Y.; Hasegawa, O.; Usuda, S. J. Med. Chem.
1981, 24, 1224.
situated in trans-relationships as shown in Figure 2 (a) and (b). This
trans-relationship was also observed in many crystalline structures
of aziridines.17 Putting both substituents of phenylethyl (X) and
methoxycarbonylethenyl (Y) groups generates the structure (c) in
Figure 2 with possible two faces, re and si, for the nucleophile to
come.
Among two possible directions re face attack is more favorable
rather than si face away from the steric hindrance, which is the
controlling factor to yield the erythro adduct as the major product
6. For more recent examples, see: (a) Jin, J.; An, M.; Sapienza, A.; Aiyar, N.;
Naselsky, D.; Sarau, H. M.; Foley, J. J.; Salyers, K. L.; Knight, S. D.; Keenan, R. M.;
Rivero, R. A.; Dhanak, D.; Douglas, S. A. Bioorg. Med. Chem. Lett. 2008, 18, 3950;
(b) Fish, P. V.; Barta, N. S.; Gray, D. L. F.; Ryckmans, T.; Stobie, A.; Wakenhut, F.;
Whitlock, G. A. Bioorg. Med. Chem. Lett. 2008, 18, 4355; (c) Wakenhut, F.; Fish, P.
V.; Fray, M. J.; Gurrell, I.; Mills, J. E.; Stobie, A.; Whitlock, G. A. Bioorg. Med.
Chem. Lett. 2008, 18, 4308.
7. (a) Pinheiro, S.; da Silva Júnior, R. C.; de Souza, A. S.; de M Carneiro, J. W.; Muri,
E. M. F.; Antunes, O. A. C. Tetrahedron. Lett. 2009, 50, 2402; (b) Hoang, C. T.;
Bouillere, F.; Johannesen, S.; Zulauf, A.; Panel, C.; Pouilhes, A.; Gori, D.; Alezra,
V.; Kouklovsky, C. J. Org. Chem. 2009, 74, 4177. and references cited therein.
8. Lee, W.-K.; Ha, H.-J. Aldrichimica Acta 2003, 36, 57. and references cited therein.
9. Park, C. S.; Choi, H. G.; Lee, H.; Lee, W. K.; Ha, H.-J. Tetrahedron: Asymmetry
2000, 11, 3283.
10. Yun, J. M.; Sim, T. B.; Hahm, H. S.; Lee, W. K.; Ha, H.-J. J. Org. Chem. 2003, 68,
7675.
11. Yoon, H. J.; Kim, Y.-W.; Lee, B. K.; Lee, W. K.; Kim, Y.; Ha, H.-J. Chem. Commun.
2007, 79.
12. Ha, H.-J.; Hong, M. C.; Ko, S. W.; Kim, Y. W.; Lee, W. K.; Park, J. Bioorg. Med.
Chem. Lett. 2006, 16, 1880.
13. Lee, B. K.; Kim, M. S.; Hahm, H. S.; Kim, D. S.; Lee, W. K.; Ha, H.-J. Tetrahedron
2006, 62, 8393.
along with the additional stereodifferentiation by (R)-a-methyl-
benzylamine. This stereochemical pathway is opposite to the reac-
tion with chelation-controlled transition state to yield the threo
product.14
The addition product 3Ac was further treated with an atmo-
spheric pressure of hydrogen in the presence of Pd(OH)2 catalyst
followed by reaction with (Boc)2O to yield (4R,5S)-4-t-butyloxy-
carbonylamino-5-methylpyrrolidin-2-one (7) in a 89% yield. Hydro-
lysis of 7 followed by anion exchange column afforded the known
(3R,4S)-4-amino-3-t-butyloxycarbonylaminopentanoic acid (8) in a
82% yield (Scheme 2).18 The addition product 3Ac will be served
as a synthetic intermediate for the preparation of various chiral dia-
mines through aziridine ring opening with various nucleophiles.8
In conclusion, the conjugate addition of benzylamine to chiral
methyl cis-3-[{(10R)-phenylethyl-aziridin}-(2R)- and (2S)-yl]-acry-
lates provides the erythro adduct, 3-(aziridin-2-yl)-3-benzylamino-
propionate as the major product. Additional stererodifferentiation
14. Suh, M.-J.; Kim, S. W.; Beak, S. I.; Ha, H.-J.; Lee, W.-K. Synlett 2004, 489.
15. (a) Pelletier, S. M.-C.; Ray, P. C.; Dixon, D. J. Org. Lett. 2009, 11, 4512; (b) Park, C.
S.; Kim, M. S.; Sim, T. B.; Pyun, D. K.; Lee, C. H.; Choi, D.; Lee, W. K.; Chang, J.-W.;
Ha, H.-J. J. Org. Chem. 2003, 68, 43.
16. In our early work we observed that the configuration of (a)-methylbenzyl
group at N1 of aziridine affected drastically the reactivity on the substitution
reaction of 2-sulfonyloxymethylaziridines. Han, S.-M.; Ma, S.-h.; Ha, H.-J.; Lee,
W. K. Tetrahedron 2008, 64, 11110.
17. (a) Lee, K.-D.; Suh, J.-M.; Park, J.-H.; Ha, H.-J.; Choi, W. G.; Park, C. S.; Chang, J.
W.; Lee, W. K.; Dong, Y.; Yun, H. Tetrahedron 2001, 57, 8267; (b) Dong, Y.; Yun,
H.; Park, C. S.; Lee, W.-K.; Ha, H.-J. Acta Crystallogr., Sect. C 2003, 59, 659.
18. Kano, S.; Yokomatsu, T.; Iwasawa, H.; Shibuya, S. Chem. Pharm. Bull. 1988, 36,
3341.
by (S)-a-methylbenzylamine to the substrate (2R)-acrylates
yielded a single enantiomeric adduct in high yield which was used
as the precursor for the substituted nitrogen-containing heterocy-
cles and enantiomerically pure b,c-diaminoacids.